These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

626 related items for PubMed ID: 27608437

  • 1. Efficacy, safety, and tolerability of adjunctive brivaracetam for secondarily generalized tonic-clonic seizures: Pooled results from three Phase III studies.
    Moseley BD, Sperling MR, Asadi-Pooya AA, Diaz A, Elmouft S, Schiemann J, Whitesides J.
    Epilepsy Res; 2016 Nov; 127():179-185. PubMed ID: 27608437
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Brivaracetam as adjunctive treatment for uncontrolled partial epilepsy in adults: a phase III randomized, double-blind, placebo-controlled trial.
    Biton V, Berkovic SF, Abou-Khalil B, Sperling MR, Johnson ME, Lu S.
    Epilepsia; 2014 Jan; 55(1):57-66. PubMed ID: 24446953
    [Abstract] [Full Text] [Related]

  • 4. Efficacy, safety, and tolerability of brivaracetam with concomitant lamotrigine or concomitant topiramate in pooled Phase III randomized, double-blind trials: A post-hoc analysis.
    Benbadis S, Klein P, Schiemann J, Diaz A, Elmoufti S, Whitesides J.
    Epilepsy Behav; 2018 Mar; 80():129-134. PubMed ID: 29414542
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Efficacy and safety of brivaracetam for partial-onset seizures in 3 pooled clinical studies.
    Ben-Menachem E, Mameniškienė R, Quarato PP, Klein P, Gamage J, Schiemann J, Johnson ME, Whitesides J, McDonough B, Eckhardt K.
    Neurology; 2016 Jul 19; 87(3):314-23. PubMed ID: 27335114
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effect of lifetime antiepileptic drug treatment history on efficacy and tolerability of adjunctive brivaracetam in adults with focal seizures: Post-hoc analysis of a randomized, placebo-controlled trial.
    Klein P, McLachlan R, Foris K, Nondonfaz X, Elmoufti S, Dimova S, Brandt C.
    Epilepsy Res; 2020 Nov 19; 167():106369. PubMed ID: 32717713
    [Abstract] [Full Text] [Related]

  • 12. A randomized, double-blind, placebo-controlled, multicenter, parallel-group study to evaluate the efficacy and safety of adjunctive brivaracetam in adult patients with uncontrolled partial-onset seizures.
    Klein P, Schiemann J, Sperling MR, Whitesides J, Liang W, Stalvey T, Brandt C, Kwan P.
    Epilepsia; 2015 Dec 19; 56(12):1890-8. PubMed ID: 26471380
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Safety, tolerability, and seizure control during long-term treatment with adjunctive brivaracetam for partial-onset seizures.
    Toledo M, Whitesides J, Schiemann J, Johnson ME, Eckhardt K, McDonough B, Borghs S, Kwan P.
    Epilepsia; 2016 Jul 19; 57(7):1139-51. PubMed ID: 27265725
    [Abstract] [Full Text] [Related]

  • 16. Time course of drug-related treatment-emergent adverse side effects of brivaracetam.
    Meador KJ, Laloyaux C, Elmoufti S, Gasalla T, Fishman J, Martin MS, Klein P.
    Epilepsy Behav; 2020 Oct 19; 111():107212. PubMed ID: 32544700
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and tolerability of adjunctive brivaracetam in adults with uncontrolled partial-onset seizures: a phase IIb, randomized, controlled trial.
    Van Paesschen W, Hirsch E, Johnson M, Falter U, von Rosenstiel P.
    Epilepsia; 2013 Jan 19; 54(1):89-97. PubMed ID: 22813235
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Brivaracetam-induced elevation of carbamazepine epoxide levels: A post-hoc analysis from the clinical development program.
    Brodie MJ, Fakhoury T, McDonough B, Colson AO, Stockis A, Elmoufti S, Whitesides J.
    Epilepsy Res; 2018 Sep 19; 145():55-62. PubMed ID: 29908435
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.